Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer

Affiliations

¹ Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
² Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94127, USA.
³ Department of Medicine, Division of Oncology and Department of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA.
⁴ Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, 02215, USA.
⁵ MRC Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK.
⁶ GlaxoSmithKline, Collegeville, PA, 19425, USA.
⁷ Cytokinetics, Inc., South San Francisco, CA, 94080, USA.
⁸ Molecular Oncology, BC Cancer Research Centre, Vancouver, Canada.
⁹ Cancer Research UK, Cambridge Institute, Cambridge, UK. carlos.caldas@cancer.org.uk.
¹⁰ Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA. Grayjo@ohsu.edu.

Published Erratum

Zhi Hu et al. Breast Cancer Res. 2017.

. 2017 Feb 9;19(1):17.

doi: 10.1186/s13058-017-0809-6.

¹ Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
² Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94127, USA.
³ Department of Medicine, Division of Oncology and Department of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA.
⁴ Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, 02215, USA.
⁵ MRC Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK.
⁶ GlaxoSmithKline, Collegeville, PA, 19425, USA.
⁷ Cytokinetics, Inc., South San Francisco, CA, 94080, USA.
⁸ Molecular Oncology, BC Cancer Research Centre, Vancouver, Canada.
⁹ Cancer Research UK, Cambridge Institute, Cambridge, UK. carlos.caldas@cancer.org.uk.
¹⁰ Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA. Grayjo@ohsu.edu.

No abstract available

Erratum for

Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.
Hu Z, Mao JH, Curtis C, Huang G, Gu S, Heiser L, Lenburg ME, Korkola JE, Bayani N, Samarajiwa S, Seoane JA, Dane MA, Esch A, Feiler HS, Wang NJ, Hardwicke MA, Laquerre S, Jackson J, W Wood K, Weber B, Spellman PT, Aparicio S, Wooster R, Caldas C, Gray JW. Hu Z, et al. Breast Cancer Res. 2016 Jul 1;18(1):70. doi: 10.1186/s13058-016-0728-y. Breast Cancer Res. 2016. PMID: 27368372 Free PMC article.

1. Hu Z, Mao JH, Curtis C, Huang G, Gu S, Heiser L, et al. Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Research. 2016;18:70. doi: 10.1186/s13058-016-0728-y. - DOI - PMC - PubMed